TheraBionic is developing treatment approaches for cancer based on the use of tumor-specific modulation frequencies, with an initial focus in hepatocellular carcinoma.
Company Location
4108 Ryan Way
Winston-Salem
NC
27106-3567
Phone
(312) 286-4703
County
Region
Company Details
Company type
Year founded
2007
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products on market
The TheraBionic P1 medical device received European regulatory approval for the treatment of advanced advanced hepatocellular carcinoma in 2018
Products under development
The TheraBionic P1 received Breakthrough Designation from tbe FDA in 2019